- The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). Hodgkinson, K.A., Parfrey, P.S., Bassett, A.S., Kupprion, C., Drenckhahn, J., Norman, M.W., Thierfelder, L., Stuckless, S.N., Dicks, E.L., McKenna, W.J., Connors, S.P. J. Am. Coll. Cardiol. (2005)